1. World Health Organization. Descriptive analysis of COVID-19-related spontaneous reports from VigiBase: interim results. 2020. https://www.who.int/medicines/regulation/medicines-safety/COVID19-PV-update4.pdf?ua=1. Accessed 1 June 2020.
2. Machhi J, Herskovitz J, Senan AM, Dutta D, Nath B, Oleynikov MD, et al. The Natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol. 2020;15(3):359–386.
3. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2020;94:91–5.
4. Jin J-M, Bai P, He W, Wu F, Liu X-F, Han D-M, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health [Internet]. 2020;8:152.
5. Osuchowski MF, Aletti F, Cavaillon J-M, Flohé SB, Giamarellos-Bourboulis EJ, Huber-Lang M, et al. SARS-CoV-2/COVID-19: Evolving reality, global response, knowledge gaps, and opportunities. Shock. 2020;54(4):416–37.